Department of Gastroenterology and Hepatology, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences, Okayama, Japan.
J Gastroenterol Hepatol. 2011 Mar;26(3):599-607. doi: 10.1111/j.1440-1746.2010.06485.x.
Laterally-spreading tumors (LST) are a newly-recognized category of colorectal neoplasia, and are defined as lesions larger than 10 mm in diameter and extending circumferentially rather than vertically. However, genetic features of this new category of tumors are not fully elucidated. The aim of this study was to evaluate genetic alterations in LST.
We examined K-ras, BRAF, and phosphoinositide-3-kinase catalytic-α polypeptide (PIK3CA) mutations in 101 LST, including 68 LST-granular type (LST-G) and 33 LST-non-granular type by direct sequencing. As controls, we examined these gene mutations in 66 protruded colon adenomas (10 mm or larger) and 44 advanced colon cancers.
K-ras, BRAF, and PIK3CA mutations were observed in 59 (58%), zero (0%), and three (3%) LST, respectively. LST-G morphology in the right-sided colon was significantly correlated with the existence of K-ras mutations, whereas a size of 20 mm or larger was the only predictor of mutations in the left-sided colorectum. The frequency of K-ras mutations in LST was particularly marked in the left-sided colorectum compared to protruded adenomas or advanced cancers (LST vs protruded adenomas, P < 0.001; LST vs advanced cancers, P = 0.002), whereas in the right-sided colon, K-ras mutations were equally frequent. PIK3CA mutations were not familiar in either LST (3%) or advanced cancers (9%).
K-ras mutations were involved in colorectal LST in different manners according to tumor location.
侧向伸展型肿瘤(LST)是一种新识别的结直肠肿瘤类别,其定义为直径大于 10mm 且呈环形而非纵向延伸的病变。然而,这种新肿瘤类别的遗传特征尚未完全阐明。本研究旨在评估 LST 的遗传改变。
我们通过直接测序,检测了 101 例 LST(包括 68 例 LST-颗粒型[LST-G]和 33 例 LST-非颗粒型)中的 K-ras、BRAF 和磷酸肌醇-3-激酶催化-α多肽(PIK3CA)突变。作为对照,我们检测了 66 例直径大于 10mm 的隆起型结肠腺瘤和 44 例晚期结肠癌中的这些基因突变。
LST 中观察到 K-ras、BRAF 和 PIK3CA 突变分别为 59(58%)、0(0%)和 3(3%)例。右侧结肠的 LST-G 形态与 K-ras 突变的存在显著相关,而 20mm 或更大的大小是左半结肠突变的唯一预测因素。与隆起型腺瘤或晚期癌症相比,LST 中 K-ras 突变的频率在左半结肠中尤其明显(LST 与隆起型腺瘤相比,P < 0.001;LST 与晚期癌症相比,P = 0.002),而在右半结肠中,K-ras 突变的频率相当。PIK3CA 突变在 LST(3%)或晚期癌症(9%)中均不常见。
根据肿瘤位置的不同,K-ras 突变以不同的方式参与结直肠 LST。